Manufacturer record

Captab Biotec: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

14 batches manufactured by Captab Biotec (Himachal Pradesh) were declared Not of Standard Quality between May 2024 and September 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: LV50333, NS-CAP Sodium Chloride Injection IP 0.9% w/v (exp Feb 2027). CDTL, Mumbai (CDSCO lab) found it not of standard quality: sample does not conform to I.P. 2022 with respect to the test for "Bacterial endotoxins". Listed in the September 2025 alert.

Records by type

14 records linked to Captab Biotec in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
14Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, May 2024 to Sep 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

14
NSQ batches since 2024
7
Products affected
Sterility
Most common failure
Sep 2025
Latest alert

Flagged batches per year

2024 · 22025 · 12

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
NS-CAP Sodium Chloride Injection IP 0.9% w/v Batch LV50333Mfg Mar 2025 · Exp Feb 2027 sample does not conform to I.P. 2022 with respect to the test for "Bacterial endotoxins"Bacterial endotoxins CDTL, MumbaiCDSCO lab Sep 2025
Sodium Chloride Injection IP 0.9 %w/v Batch LV4983Mfg Nov 2024 · Exp Oct 2026 Bacterial endotoxins and SterilitySterility RDTL ChandigarhCDSCO lab Apr 2025
Sodium Chloride Injection IP 0.9 %w/v Batch LV4979Mfg Nov 2024 · Exp Oct 2026 Bacterial endotoxins and SterilitySterility RDTL ChandigarhCDSCO lab Apr 2025
Sodium Chloride Injection IP 0.9 %w/v Batch LV4987Mfg Nov 2024 · Exp Oct 2026 Bacterial endotoxins and SterilitySterility RDTL ChandigarhCDSCO lab Apr 2025
Sodium Chloride Injection IP 0.9 %w/v Batch LV4984Mfg Nov 2024 · Exp Oct 2026 Bacterial endotoxins and SterilitySterility RDTL ChandigarhCDSCO lab Apr 2025
Sodium Chloride Injection IP 0.9 %w/v Batch LV4985Mfg Nov 2024 · Exp Oct 2026 Bacterial endotoxins and SterilitySterility RDTL ChandigarhCDSCO lab Apr 2025
Sodium Chloride Injection IP 0.9 %w/v Batch LV4982Mfg Nov 2024 · Exp Oct 2026 Bacterial endotoxins and SterilitySterility RDTL ChandigarhCDSCO lab Apr 2025
Sodium Chloride Injection IP 0.9 %w/v Batch LV4978Mfg Nov 2024 · Exp Oct 2026 Bacterial endotoxins and SterilitySterility RDTL ChandigarhCDSCO lab Apr 2025
Sodium Chloride Injection IP 0.9 %w/v Batch LV4988Mfg Nov 2024 · Exp Oct 2026 Particulate matter, Bacterial endotoxins and SterilitySterility RDTL ChandigarhCDSCO lab Apr 2025
Ceftriaxone and Salbactam for Injection 1.5 g (TriaxS 1.5 g) Batch DC40117Mfg Sep 2024 · Exp Aug 2027 Particulate Matter and DescriptionDescription CDL, KolkataCDSCO lab Mar 2025
Ofloxacin Ophthanmic Solution IP (Ocuex Eye Drops) Batch ED4648Mfg Nov 2024 · Exp Oct 2026 Assay of OfloxacinAssay CDL KolkataCDSCO lab Jan 2025
Ciprofloxacin Injection IP Batch LV4210Mfg Mar 2024 · Exp Feb 2026 In test of Lactic Acid per mg of CiprofloxacinOther RDTL ChandigarhCDSCO lab Jan 2025
Ceftriaxone for Injection I.P. 1 gm Batch DC30119Mfg Oct 2023 · Exp Sep 2025 Particulate matterParticulate matter CDL KolkataCDSCO lab Jun 2024
Ceftriaxone for InjectionI.P.1gm Batch DC3011 9Mfg Oct 2023 · Exp Sep 2025 The sample does not conforms to I.P. with respect to test for "Particulate MatterParticulate matter CDL KolkataCDSCO lab May 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.